Migraine and stroke are neurovascular disorders causing a significant burden on both patients and the economy. A potential causal link between migraine and stroke has been suggested, but several knowledge gaps remain.
The current study is based on an ongoing prospective population-based cohort study, called the Rotterdam Study, which investigates the determinants and occurrence of cardiovascular, neurological, ophthalmological, psychiatric, and endocrine diseases [1]. “In different cohorts, we assessed the baseline migraine between 2006 and 2011 and followed those participants for the occurrence of stroke,” Mr Cevdet Acarsoy (Erasmus Medical Centre, the Netherlands) explained.
Prevalent migraine was determined at baseline in an interview with a qualified physician and verified from medical records. Then, participants were continuously monitored for incident strokes by means of linking study databases with files from general practitioners or nursing home records. Additionally, imaging reports were obtained from hospital reports, to ascertain stroke subtypes as ischaemic, haemorrhagic, or unspecified.
Included were 6,925 participants (mean age 65.7, 57.8% women) who did not suffer from a previous stroke. At baseline, 1,030 (14.9%) participants met the criteria for migraine, of whom 402 had active migraine and 210 had migraine with aura.
After a median follow-up of 6.4 years, 195 participants suffered a stroke. Follow-up was complete for 95.3% of potential person-years. “Although we found a trend for an association between migraine and stroke (HR 1.40), this association was not statistically significant (P=0.83; see Figure),” Mr Acarsoy said.
Figure: Kaplan-Meier survival curves for the probability of stroke-free survival in individuals with or without migraine [1]

When repeating the analysis for the different subtypes of migraine, results remained consistent:
- active versus non-active, HR 1.59; and
- aura present versus absent, HR 1.45.
Moreover, concerning stroke subtypes, the investigators found no significant association with ischaemic stroke (HR 1.45).
- Acarsoy C, et al. Migraine is not Associated with Incident Stroke: The Rotterdam Study. AL016, IHC 2021, 8–12 September.
Copyright ©2021 Medicom Medical Publishers
Posted on
Previous Article
« Predictors of health-related quality of life in cluster headache Next Article
AI-enabled ECG algorithm predicts atrial fibrillation risk in migraine »
« Predictors of health-related quality of life in cluster headache Next Article
AI-enabled ECG algorithm predicts atrial fibrillation risk in migraine »
Table of Contents: IHC 2021
Featured articles
Letter from the Editor
COVID-19
Telemedicine beneficial for headache care during the pandemic
Comparison of headaches after SARS-CoV-2 vaccination
Grey matter cortical changes in patients with persistent headache after COVID-19
Increased risk of cerebral venous thrombosis in COVID-19
Patient Perception and Symptoms
Predictors of health-related quality of life in cluster headache
Dry eye disease is more prevalent in migraine
Voice change and throat swelling are cranial autonomic symptoms in primary headache
Association between physical inactivity and headache disorders
Increased suicidal attempts and risks of ideation in medication-overuse headache
Cardioembolic Comorbidities
AI-enabled ECG algorithm predicts atrial fibrillation risk in migraine
Migraine may not be a risk factor for stroke
Imaging
Functional brainstem somatotopy of the trigeminal nerve during nociception
Morphological changes in cluster headache between attacks
Interictal pontine metabolism in migraine patients without aura
Genome-Wide Association Studies
Largest genome-wide association study of migraine to date
Robust evidence that cluster headache has a genetic basis
Pharmacological Treatment
Insights in drug-drug interactions facilitate rational polypharmacy
Rimegepant confers long-term improvements in MMDs
First real-world effectiveness data of erenumab is promising
Galcanezumab effective in patients with episodic or chronic cluster headache
Central effects and affected somatosensory processing with galcanezumab in migraine
Long-term safety and tolerability of atogepant in migraine
Non-Pharmacological Treatment
Occipital nerve stimulation effective and safe in chronic cluster headache
Related Articles

November 8, 2021
Interictal pontine metabolism in migraine patients without aura
September 9, 2020
Unmet needs and pipeline
November 8, 2021
Insights in drug-drug interactions facilitate rational polypharmacy
© 2023 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy